Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jacklin Gukasyan"'
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a307601d2160103eafd1495949141b22
https://doi.org/10.1158/1078-0432.22474590
https://doi.org/10.1158/1078-0432.22474590
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Supplementary Table Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5138f4395cc71838ec71dedb3912974e
https://doi.org/10.1158/1078-0432.22474584
https://doi.org/10.1158/1078-0432.22474584
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Supplemental Figure 1. Schematic presentation of the analyzed parameters in the correlative cohort per progression survival (PFS). TMB: total mutational burden. PR: partial response. SD: stable disease. PD: progressive disease. â-³: mutation. Suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b89a8af93b3d7203be941dd8e3cdd93
https://doi.org/10.1158/1078-0432.22474587
https://doi.org/10.1158/1078-0432.22474587
Autor:
Edward B. Garon, Antoni Ribas, Matthew D. Hellmann, David Elashoff, Jonathan W. Goldman, Steven Dubinett, Dennis Slamon, I. Peter Shintaku, Jacklin Gukasyan, Benjamin Jones, John Madrigal, Amy Cummings, James Carroll, Daniel K. Wells, Hira Rizvi, Tristan R. Grogan, Jesse M. Zaretsky, Aaron Lisberg, Siwen Hu-Lieskovan
Purpose:Several biomarkers have been individually associated with response to PD-1 blockade, including PD-L1 and tumor mutational burden (TMB) in non–small cell lung cancer (NSCLC), and CD8 cells in melanoma. We sought to examine the relationship b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e0f397fda69c30f797882bbb41ddfb
https://doi.org/10.1158/1078-0432.c.6528828
https://doi.org/10.1158/1078-0432.c.6528828
Autor:
Jesse M. Zaretsky, Jacklin Gukasyan, John Madrigal, James M. Carroll, David Elashoff, Steven M. Dubinett, Jonathan W. Goldman, Daniel K. Wells, I. Peter Shintaku, Edward B. Garon, Antoni Ribas, Hira Rizvi, Benjamin P Jones, Dennis J. Slamon, Siwen Hu-Lieskovan, Aaron Lisberg, Matthew D. Hellmann, Tristan Grogan, Amy L. Cummings
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(16)
Purpose: Several biomarkers have been individually associated with response to PD-1 blockade, including PD-L1 and tumor mutational burden (TMB) in non–small cell lung cancer (NSCLC), and CD8 cells in melanoma. We sought to examine the relationship